vs

Side-by-side financial comparison of Arteris, Inc. (AIP) and LIFECORE BIOMEDICAL, INC. \DE\ (LFCR). Click either name above to swap in a different company.

LIFECORE BIOMEDICAL, INC. \DE\ is the larger business by last-quarter revenue ($31.1M vs $20.1M, roughly 1.5× Arteris, Inc.). LIFECORE BIOMEDICAL, INC. \DE\ runs the higher net margin — -32.1% vs -42.2%, a 10.1% gap on every dollar of revenue. On growth, Arteris, Inc. posted the faster year-over-year revenue change (30.0% vs -4.5%). Arteris, Inc. produced more free cash flow last quarter ($3.0M vs $25.0K). Over the past eight quarters, Arteris, Inc.'s revenue compounded faster (24.7% CAGR vs -0.1%).

Arteris, Inc. is a multinational technology company headquartered in Campbell, California. It develops the network-on-chip (NoC) IP and system-on-chip (SoC) integration automation software that is used to create semiconductor chip and chiplet designs for a variety of devices, particularly in automotive electronics, artificial intelligence, machine learning, enterprise computing, communications, consumer, industrial, and aerospace & defense markets. The company specializes in the development a...

LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.

AIP vs LFCR — Head-to-Head

Bigger by revenue
LFCR
LFCR
1.5× larger
LFCR
$31.1M
$20.1M
AIP
Growing faster (revenue YoY)
AIP
AIP
+34.5% gap
AIP
30.0%
-4.5%
LFCR
Higher net margin
LFCR
LFCR
10.1% more per $
LFCR
-32.1%
-42.2%
AIP
More free cash flow
AIP
AIP
$3.0M more FCF
AIP
$3.0M
$25.0K
LFCR
Faster 2-yr revenue CAGR
AIP
AIP
Annualised
AIP
24.7%
-0.1%
LFCR

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
AIP
AIP
LFCR
LFCR
Revenue
$20.1M
$31.1M
Net Profit
$-8.5M
$-10.0M
Gross Margin
90.8%
25.0%
Operating Margin
-42.0%
-9.9%
Net Margin
-42.2%
-32.1%
Revenue YoY
30.0%
-4.5%
Net Profit YoY
-3.7%
-52.0%
EPS (diluted)
$-0.19
$-0.29

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AIP
AIP
LFCR
LFCR
Q4 25
$20.1M
Q3 25
$17.4M
$31.1M
Q2 25
$16.5M
Q1 25
$16.5M
$35.2M
Q4 24
$15.5M
$32.6M
Q3 24
$14.7M
$24.7M
Q2 24
$14.6M
Q1 24
$12.9M
$35.7M
Net Profit
AIP
AIP
LFCR
LFCR
Q4 25
$-8.5M
Q3 25
$-9.0M
$-10.0M
Q2 25
$-9.1M
Q1 25
$-8.1M
$-14.8M
Q4 24
$-8.2M
$-6.6M
Q3 24
$-7.7M
$-16.2M
Q2 24
$-8.3M
Q1 24
$-9.4M
$15.6M
Gross Margin
AIP
AIP
LFCR
LFCR
Q4 25
90.8%
Q3 25
89.9%
25.0%
Q2 25
89.4%
Q1 25
90.8%
28.0%
Q4 24
89.8%
34.0%
Q3 24
90.1%
21.8%
Q2 24
90.0%
Q1 24
88.7%
33.3%
Operating Margin
AIP
AIP
LFCR
LFCR
Q4 25
-42.0%
Q3 25
-50.1%
-9.9%
Q2 25
-50.0%
Q1 25
-46.6%
-25.7%
Q4 24
-45.9%
-6.0%
Q3 24
-53.8%
-46.9%
Q2 24
-51.1%
Q1 24
-70.5%
-2.5%
Net Margin
AIP
AIP
LFCR
LFCR
Q4 25
-42.2%
Q3 25
-51.6%
-32.1%
Q2 25
-55.3%
Q1 25
-49.1%
-42.0%
Q4 24
-53.0%
-20.2%
Q3 24
-52.2%
-65.7%
Q2 24
-57.2%
Q1 24
-72.6%
43.8%
EPS (diluted)
AIP
AIP
LFCR
LFCR
Q4 25
$-0.19
Q3 25
$-0.21
$-0.29
Q2 25
$-0.22
Q1 25
$-0.20
$-0.47
Q4 24
$-0.19
$-0.25
Q3 24
$-0.20
$-0.53
Q2 24
$-0.22
Q1 24
$-0.25
$0.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AIP
AIP
LFCR
LFCR
Cash + ST InvestmentsLiquidity on hand
$33.9M
$18.9M
Total DebtLower is stronger
$136.0M
Stockholders' EquityBook value
$-14.6M
$-10.5M
Total Assets
$115.0M
$235.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AIP
AIP
LFCR
LFCR
Q4 25
$33.9M
Q3 25
$39.0M
$18.9M
Q2 25
$38.0M
Q1 25
$42.3M
$5.4M
Q4 24
$43.8M
$9.5M
Q3 24
$48.7M
Q2 24
$45.8M
Q1 24
$44.8M
Total Debt
AIP
AIP
LFCR
LFCR
Q4 25
Q3 25
$136.0M
Q2 25
Q1 25
$124.9M
Q4 24
$111.3M
Q3 24
$106.3M
Q2 24
Q1 24
$97.1M
Stockholders' Equity
AIP
AIP
LFCR
LFCR
Q4 25
$-14.6M
Q3 25
$-11.4M
$-10.5M
Q2 25
$-7.5M
Q1 25
$-4.8M
$2.2M
Q4 24
$-1.2M
$15.4M
Q3 24
$2.2M
$-3.9M
Q2 24
$5.3M
Q1 24
$9.5M
$17.7M
Total Assets
AIP
AIP
LFCR
LFCR
Q4 25
$115.0M
Q3 25
$107.7M
$235.2M
Q2 25
$106.9M
Q1 25
$98.3M
$237.7M
Q4 24
$106.1M
$255.4M
Q3 24
$97.7M
$246.8M
Q2 24
$96.4M
Q1 24
$101.4M
$246.2M
Debt / Equity
AIP
AIP
LFCR
LFCR
Q4 25
Q3 25
Q2 25
Q1 25
56.05×
Q4 24
7.20×
Q3 24
Q2 24
Q1 24
5.49×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AIP
AIP
LFCR
LFCR
Operating Cash FlowLast quarter
$3.2M
$1.8M
Free Cash FlowOCF − Capex
$3.0M
$25.0K
FCF MarginFCF / Revenue
15.1%
0.1%
Capex IntensityCapex / Revenue
0.7%
5.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$5.3M
$-16.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AIP
AIP
LFCR
LFCR
Q4 25
$3.2M
Q3 25
$3.2M
$1.8M
Q2 25
$-2.5M
Q1 25
$2.9M
$1.2M
Q4 24
$-2.6M
$-6.1M
Q3 24
$1.1M
$-613.0K
Q2 24
$311.0K
Q1 24
$477.0K
$-1.4M
Free Cash Flow
AIP
AIP
LFCR
LFCR
Q4 25
$3.0M
Q3 25
$2.5M
$25.0K
Q2 25
$-2.8M
Q1 25
$2.7M
$-4.3M
Q4 24
$-2.7M
$-8.6M
Q3 24
$1.1M
$-4.0M
Q2 24
$264.0K
Q1 24
$281.0K
$-7.8M
FCF Margin
AIP
AIP
LFCR
LFCR
Q4 25
15.1%
Q3 25
14.2%
0.1%
Q2 25
-17.2%
Q1 25
16.2%
-12.1%
Q4 24
-17.3%
-26.3%
Q3 24
7.4%
-16.3%
Q2 24
1.8%
Q1 24
2.2%
-21.8%
Capex Intensity
AIP
AIP
LFCR
LFCR
Q4 25
0.7%
Q3 25
4.1%
5.6%
Q2 25
2.2%
Q1 25
1.1%
15.5%
Q4 24
0.3%
7.5%
Q3 24
0.2%
13.9%
Q2 24
0.3%
Q1 24
1.5%
17.8%
Cash Conversion
AIP
AIP
LFCR
LFCR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
-0.09×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AIP
AIP

License And Maintenance$17.5M87%
Variable Royalties And Other$2.6M13%

LFCR
LFCR

Transferred At Point In Time$26.6M85%
Transferred Over Time$4.5M15%

Related Comparisons